Guido Oelkers joins Nycomed Executive Committee

16.05.2008

New leadership for Commercial Operations

 

Nycomed today announced the appointment of Guido Oelkers as the new Executive Vice President Commercial Operations. It is planned that he joins Nycomed in September 2008. Based in Zurich, Guido Oelkers will be in charge of all Commercial Operations and its Area Managers, with the exception of Russia/CIS.

Guido Oelkers has been working in the pharmaceutical and healthcare industry since 1984. He headed various country organisations of Hoechst AG and Aventis in China, Indonesia and New Zealand. He broadened his international exposure as Executive Vice President Healthcare of DKSH, where he was responsible for the global Healthcare business with focus on Asia and Europe. In his current role as Chief Executive Officer of INVIDA, Singapore, he transformed the organisation into one of the largest Asian-based specialty pharmaceutical companies.

An economist by training, Guido Oelkers holds a Ph.D. in strategic management from the University of South Australia. He completed his undergraduate and graduate studies at various universities in Germany and the UK.

“I am delighted to welcome Guido Oelkers as our new Executive Vice President for Commercial Operations,” says Håkan Björklund, Chief Executive Officer of Nycomed. “He brings to Nycomed a wealth of skills and international experience. His strong pharmaceutical sales background, proven commercial results and energetic leadership style will be great assets.”

 

 

About Nycomed
Nycomed is a privately owned pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets.

 

The company is active in a range of therapeutic areas. Its key products are aimed at gastroenterology, pain management, osteoporosis, respiratory diseases and tissue management. New products are sourced both from our own research and from business partners.

 

Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide.

 

The combined group employs over 11,500 people. In 2007, it had annual sales of € 3.5 billion and an adjusted EBITDA of € 1.2 billion.

 

For more information visit www.nycomed.com

 

For further information

 

Media:
Tobias Cottmann, Director External Communications
Phone +41 44 555 15 10

 

Investors:
Christian B. Seidelin, Vice President Controlling, Treasury and Insurance
Phone +41 44 555 11 04

 

 

For further information

Media:
General phone:

+41 44 555 15 10
Beatrix Benz,

phone: +41 44 555 1508
Tobias Cottmann,

phone: +41 44 555 1501

Investors:
Christian B. Seidelin,

phone: +41 44 555 11 04

Related information


English PDF
German PDF

Top of page

Takeda Pharma